195 related articles for article (PubMed ID: 32586474)
1. Diabetes and Heart Failure: A Marriage of Inconvenience.
Mehta A; Bhattacharya S; Estep J; Faiman C
Clin Geriatr Med; 2020 Aug; 36(3):447-455. PubMed ID: 32586474
[TBL] [Abstract][Full Text] [Related]
2. Heart Failure in Type 2 Diabetes Mellitus.
Kenny HC; Abel ED
Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
[TBL] [Abstract][Full Text] [Related]
3. What's new in heart failure in the patient with type 2 diabetes?
Camafort M
Endocrinol Nutr; 2015; 62(7):350-5. PubMed ID: 26228800
[TBL] [Abstract][Full Text] [Related]
4. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure.
Osuna PM; Brown SJ; Tabatabai LS; Hamilton DJ
Methodist Debakey Cardiovasc J; 2018; 14(4):257-265. PubMed ID: 30788011
[TBL] [Abstract][Full Text] [Related]
5. Counterpoint to the hypothesis that SGLT2 inhibitors protect the heart by antagonizing leptin.
Avogaro A; Fadini GP
Diabetes Obes Metab; 2018 Jun; 20(6):1367-1368. PubMed ID: 29377537
[No Abstract] [Full Text] [Related]
6. [Diabetes and heart failure : Update 2017].
Schütt K; Marx N
Herz; 2017 May; 42(3):329-340. PubMed ID: 28396903
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.
Arturi F; Succurro E; Miceli S; Cloro C; Ruffo M; Maio R; Perticone M; Sesti G; Perticone F
Endocrine; 2017 Sep; 57(3):464-473. PubMed ID: 27830456
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.
Dei Cas A; Spigoni V; Ridolfi V; Metra M
Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):38-50. PubMed ID: 23369136
[TBL] [Abstract][Full Text] [Related]
9. Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.
Dungan K; Binkley P; Osei K
J Diabetes Complications; 2016; 30(1):150-4. PubMed ID: 26475503
[TBL] [Abstract][Full Text] [Related]
10. [Diabetes and heart failure: a practically oriented critical appraisal].
Halle M; Gitt AK; Hanefeld M; Kellerer M; Marx N; Meier JJ; Schumm-Draeger PM; Bramlage P; Tschoepe D
Dtsch Med Wochenschr; 2012 Mar; 137(9):437-41. PubMed ID: 22354800
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on models of diabetic heart disease.
Heather LC; Hafstad AD; Halade GV; Harmancey R; Mellor KM; Mishra PK; Mulvihill EE; Nabben M; Nakamura M; Rider OJ; Ruiz M; Wende AR; Ussher JR
Am J Physiol Heart Circ Physiol; 2022 Jul; 323(1):H176-H200. PubMed ID: 35657616
[TBL] [Abstract][Full Text] [Related]
12. [Congestive heart failure and diabetes mellitus: an intricated relationship].
De Flines J; Scheen AJ
Rev Med Liege; 2007 Feb; 62(2):112-7. PubMed ID: 17461301
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic medications in patients with heart failure.
Samia El Hayek MM; Beydoun MF; Azar ST
Minerva Endocrinol; 2017 Mar; 42(1):53-63. PubMed ID: 27195949
[TBL] [Abstract][Full Text] [Related]
14. How Diabetes and Heart Failure Modulate Each Other and Condition Management.
Randhawa VK; Dhanvantari S; Connelly KA
Can J Cardiol; 2021 Apr; 37(4):595-608. PubMed ID: 33276047
[TBL] [Abstract][Full Text] [Related]
15. EMPA-REG - the "diuretic hypothesis".
McMurray J
J Diabetes Complications; 2016; 30(1):3-4. PubMed ID: 26597600
[No Abstract] [Full Text] [Related]
16. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies.
Fitchett D
Can J Diabetes; 2015 Dec; 39 Suppl 5():S176-82. PubMed ID: 26654861
[No Abstract] [Full Text] [Related]
18. Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.
Packer M
Diabetes Obes Metab; 2018 Jun; 20(6):1361-1366. PubMed ID: 29359851
[TBL] [Abstract][Full Text] [Related]
19. Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
Packer M
Circulation; 2019 Aug; 140(6):443-445. PubMed ID: 31381418
[No Abstract] [Full Text] [Related]
20. Predictors of heart failure development in type 2 diabetes: a practical approach.
Verma S; Sharma A; Kanumilli N; Butler J
Curr Opin Cardiol; 2019 Sep; 34(5):578-583. PubMed ID: 31219877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
